Researchers identified and began characterizing carbapenemase-producing bacteria from wastewater samples in ICU pipes and other sites at an NIH hospital.
The BD MAX Check-Points CPO assay detects common carbapenemase-producing organisms in less than 2.5 hours.
Using MRSA isolates from England, researchers uncovered hospital-specific, community-specific, and overlapping transmission clusters.
The ASM speaker said that strains collected from two different hospital systems also exhibited overlap in their SNP and other content.
The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.
The researchers analyzed DNA from more than 6,500 samples taken from patients, staff, patient rooms, nurse stations, water, and air.
Researchers described a vancomycin-resistant Enterococcus infection transmitted from a liver donor to recipient, ruling out hospital-acquired infection with genomics.
The company recently presented preliminary results from two large-scale studies on tracking infections and drug resistance in large hospital systems.
Danaher said that it expects the acquisition to be accretive to earnings in the fifth full year post acquisition.
The test is the 20th US-IVD molecular diagnostic on the GeneXpert menu — Cepheid also recently announced that it has now placed its 10,000 systems globally.
In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.
The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.
Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.
In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.